0001171843-24-001304.txt : 20240312 0001171843-24-001304.hdr.sgml : 20240312 20240312200128 ACCESSION NUMBER: 0001171843-24-001304 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levitz Michael L CENTRAL INDEX KEY: 0001468019 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 24744152 MAIL ADDRESS: STREET 1: C/O ANALOGIC CORPORATION STREET 2: 8 CENTENNIAL DRIVE CITY: PEABODY STATE: MA ZIP: 01960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0508 4 2024-03-11 0 0000898437 Anika Therapeutics, Inc. ANIK 0001468019 Levitz Michael L 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 EVP, CFO, Treasurer 0 Common Stock 2024-03-11 4 M 0 4438 0 A 37830 D Common Stock 2024-03-11 4 F 0 1303 25.42 D 36527 D Common Stock 2024-03-11 4 M 0 5875 0 A 42402 D Common Stock 2024-03-11 4 F 0 1725 25.42 D 40677 D Common Stock 2024-03-11 4 M 0 8888 0 A 49565 D Common Stock 2024-03-11 4 F 0 2610 25.79 D 46955 D Restricted Stock Unit 0.00 2024-03-11 4 M 0 4438 0 D Common Stock 4438 0 D Restricted Stock Unit 0.00 2024-03-11 4 M 0 5875 0 D Common Stock 5875 11749 D Restricted Stock Unit 0.00 2024-03-11 4 M 0 8888 0 D Common Stock 8888 8888 D Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. Includes 160 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on November 14, 2023. Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations. Reflects the first vesting installment of RSUs granted on March 9, 2023. Reflects an aggregate of 1,725 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024. Reflects the second vesting installment of RSUs granted on March 11, 2022. Reflects an aggregate of 2,610 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024. Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. /s/ Michael L. Levitz 2024-03-12